Press Releases

Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc. has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the investigational drug voclosporin, following recent positive Phase 3 results.

Atik Cameras Develops New Products for Use with qPCR Instruments for Accurate, Reliable COVID-19 Testing

Atik Cameras today announced the launch of the VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments for accurate, reliable COVID-19 Testing – which I thought would be of interest to you and your readers. The qPCR test is vital in pinpointing COVID-19 positive cases and the timeframes in which these cases pose the greatest risk of spreading the SARS-CoV-2 virus to the wider population. With the paramount importance of the COVID-19 challenge, it was vital that Atik Cameras provided products that were well suited to the task. The commercially-competitive, custom VS255 and VS825 cameras offer superior sensitivity and image quality enabling Original Equipment Manufacturers (OEMs) and clinical diagnostic laboratories to achieve accurate diagnosis of active COVID-19 infections.

Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials

A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials – which I thought would be of interest to you and your readers. The success rate of clinical trials is just 14%, with patient recruitment being a key hurdle. Wirano aims to improve this rate by optimizing the patient recruitment process, improving site and investigator selection procedures, and creating reliable channels for effective communication between all participants.

BOC Sciences Lanuched A New Biotinylation Platform

Global Genes and Rady Children’s Institute for Genomic Medicine Partner to Develop Next-Generation Support Network for Families with Diagnosed Gene-Based Rare Diseases

Global Genes, a leading rare disease patient advocacy organization, is pleased to announce a new partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) to develop a next-generation support network for families with gene-based diagnosed rare diseases.

Notable Labs Announces Addition of Thomas Bock to Board of Directors

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Dr. Thomas A. Bock to its board of directors.

Knowledge to Practice (K2P) Appoints David B. Nash, MD, MBA, as Chairman of Advisory Board

Knowledge to Practice (K2P), a leading provider of personalized, competency-based lifelong learning for practicing physicians, hospitals and healthcare systems, today announced it has named David B. Nash, MD, MBA, as Chairman of its Advisory Board. A board-certified internist and the Founding Dean Emeritus at Jefferson College of Population Health, Dr. Nash advised on the development of the recently launched CurrentMD COVID curriculum and is helping to conceptualize K2P’s new Complex Diseases curriculum, set to launch in 2021.

WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™

WCG has unified its five IRBs – Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB, and Aspire IRB – in a single brand, WCG IRB. It has also launched a new technology – WCG IRB Connexus – to support clients’ ethical review submissions and management. Further information is available on it new website at www.wcgirb.com.

CATO SMS Unveils New Brand

CATO SMS unveiled its new brand today, revealing an updated look and logo capturing the company’s powerful offering following the merger of CATO Research, LLC and Specialized Medical Services-oncology BV (SMS-oncology).

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion

Digital therapeutics leader Biofourmis closes $100 million Series C led by SoftBank. Funds will help accelerate virtual clinical trials business, among other initiatives.

Patient Groups Issue Guidelines for Ensuring Access to Care and Treatment for Rare Disease Patients, Citing Critical Needs and Gaps Further Exposed and Stretched During COVID-19

Global Genes and the Child Neurology Foundation, as part of the Rare Access to Critical Therapies (ACT) collaboration, announced today the joint release of a report highlighting and supporting guiding principles of rare disease care and access — which the groups assert are universally relevant to all patients with rare diseases.

Litmus Health Achieves HIPAA Compliance and NIST Cybersecurity Framework Adherence for Real World Data Infrastructure

Litmus Health, the research-ready infrastructure platform for real world data, that you might find interesting. As a bit of background, Litmus collects real world data from wearables and sensors, and analyzes these data for inclusion in clinical trials for their customers in pharma. This morning, the company announced that after a thorough third party security assessment, its infrastructure was determined to be secure and compliant when measured against federal security regulations.

APIS Assay Technologies Ltd expands bioinformatics expertise with acquisition of Beogenomics

Please see below for the latest news from APIS Assay Technologies Ltd announcing the acquisition of Beogenomics, a specialised software developer with major expertise in Bioinformatics and Artificial Intelligence (BIOX). Beogenomics develops both on-prem and secure cloud-based data analysis solutions — helping customers design, build and run custom tailored genomics & proteomics pipelines. The integration into Manchester-based APIS will support the launch of a new BIOX Service Line as part of the company’s ongoing Biomarker Research and Development activities.

ECCRT and IDDI establish partnership for continuous development of IDDI global team members

European Centre for Clinical Research Training (ECCRT) has been selected as a premium provider for continuous online learning by IDDI, a BIOSTATISTICAL AND ECLINICAL SERVICES provider for Pharmaceutical and Biotechnology companies. ECCRT will provide access to the eLearning ‘Virtual Campus’ platform that will allow IDDI’s global staff members to attend ICH Good Clinical Practice and related trainings.

WEP Clinical joins with Wren Healthcare to provide home healthcare services

WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU.

CATO SMS ACQUIRES ARRAY BIOSTATISTICS

CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions.

Matexcel Offers a Wide Selection of Natural Materials for Research Needs

Lifeasible Provides Virus-like Particles Production in Plant

Profacgen Provides Data Analysis Service for Biological Discovery

Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease

The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global Phase 3, randomized, double-blind, placebo-controlled, parallel arm, multicenter study evaluating the efficacy and safety of pridopidine in patients with early stage HD.